SC Denies Petition on COVID-19 Vaccine Side Effects: A Bold Rebuke to Sensationalism
The Supreme Court of India dismissed a petition on Monday that claimed COVID-19 vaccines were responsible for side effects like blood clotting. A bench led by Chief Justice DY Chandrachud, with Justices JB Pardiwala and Manoj Misra, rejected the plea, labeling it as an attempt to incite unnecessary concern.
In its decision, the court highlighted the insignificance of the petition, underscoring the risks if the vaccine rollout had not occurred. “We don’t want to rake this up, this is just to create a sensation,” the bench noted, questioning the validity and usefulness of the claims presented.
During the hearing, the justices also addressed the petitioner’s attorney, inquiring whether he had received the vaccine himself. The lawyer confirmed he had been vaccinated and reported experiencing no adverse effects. The petition, initiated by Priya Mishra and others, sought to challenge the purported adverse impacts of the COVID-19 vaccines, yet the court found it lacking in substantial evidence or necessity.
The dismissal underscores the judiciary’s stance on the importance of the vaccination program and its confidence in the vaccine’s safety profile. Through this decision, the court aimed to reaffirm public trust in the COVID-19 vaccination initiative, crucial in managing the pandemic effectively.
The ruling reflects the broader judicial perspective on promoting public health measures while deterring unsubstantiated alarm regarding vaccines. The court’s response serves both as a reminder of the critical role vaccines play in curbing the pandemic and a warning against spreading misinformation that could hamper public health efforts. This dismissal stands as a significant assertion of support for science-based health policies in India’s ongoing fight against COVID-19.
Original Story https://www.indiatodayne.in/national/story/sc-dismisses-petition-on-covid-19-vaccine-side-effects-calls-it-attempt-to-create-sensation-1106121-2024-10-14?utm_source=rssfeed
Category :
Tags: